Schedule 13G ownership disclosure

ALX Oncology Holdings, Inc.

Security class unavailable · CUSIP: 00166B105

Event date: 2022-05-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,128,101
Percent of class
2.7700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-22-000039
Form type
SC 13G/A
Filer
ALX ONCOLOGY HOLDINGS INC
CIK
CIK 1810182
Filed
Jun 10, 2022
Reporting period
May 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub